Ipca Laboratories Ltd
NSE :IPCALAB BSE :524494 Sector : PharmaceuticalsBuy, Sell or Hold IPCALAB? Ask The Analyst
BSE
prev close
OPEN PRICE
bid price (qty)
offer price (qty)
volume
Today's low / high
52 WK low / high
NSE
prev close
open price
bid price (qty)
offer price (qty)
volume
Today's' low / high
52 WK low / high
26 Apr 1338.50 (0.76%) | 25 Apr 1328.45 (-1.40%) | 24 Apr 1347.25 (1.76%) | 23 Apr 1323.95 (-0.38%) | 22 Apr 1328.95 (-0.67%) | 19 Apr 1337.95 (-1.06%) | 18 Apr 1352.30 (0.81%) | 16 Apr 1341.50 (1.04%) | 15 Apr 1327.65 (-0.85%) | 12 Apr 1339.00 (0.61%) | 10 Apr 1330.85 (0.66%) | 09 Apr 1322.15 (2.14%) | 08 Apr 1294.50 (-1.53%) | 05 Apr 1314.55 (3.01%) | 04 Apr 1276.15 (4.23%) | 03 Apr 1224.35 (-0.75%) | 02 Apr 1233.55 (-0.60%) | 01 Apr 1241.05 (0.29%) | 28 Mar 1237.40 (2.66%) | 27 Mar 1205.30 (0.37%) | 26 Mar 1200.90 (0.41%) |
Price Chart Historical Data Technical Chart
Technical Analysis
Short Term Investors
Very Bullish
Medium Term Investors
Very Bullish
Long Term Investors
Very Bullish
Moving Averages
5 DMA
Bullish
1333.25
10 DMA
Bullish
1336.42
20 DMA
Bullish
1301.64
50 DMA
Bullish
1234.2
100 DMA
Bullish
1176.08
200 DMA
Bullish
1050.26
Intraday Support and Resistance
(Based on Pivot Points) |
Updated On Apr 26, 2024 04:00 PM For Next Trading Session
Pivots | Classic | Fibonacci | Camarilla | Woodie | DM |
---|---|---|---|---|---|
R3 | 1358.91 | 1351.43 | 1342.34 | - | - |
R2 | 1351.43 | 1346.1 | 1341.06 | 1351.69 | - |
R1 | 1344.96 | 1342.81 | 1339.78 | 1345.48 | 1348.2 |
P | 1337.48 | 1337.48 | 1337.48 | 1337.74 | 1339.1 |
S1 | 1331.01 | 1332.15 | 1337.22 | 1331.53 | 1334.25 |
S2 | 1323.53 | 1328.86 | 1335.94 | 1323.79 | - |
S3 | 1317.06 | 1323.53 | 1334.66 | - | - |
Key Metrics
EPS
21.7
P/E
61.69
P/B
5.47
Dividend Yield
0.3%
Market Cap
33,958 Cr.
Face Value
1
Book Value
244.58
ROE
8.7%
EBITDA Growth
420.79 Cr.
Debt/Equity
0.2
Shareholding History
Quarterly Result (Figures in Rs. Crores)
Ipca Laboratories Ltd Quaterly Results
Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | |
INCOME | 1576.89 | 1548.02 | 1630.06 | 2072.51 | 2143.32 |
PROFIT | 107.84 | 76.52 | 162.82 | 145.06 | 127.53 |
EPS | 4.25 | 3.02 | 6.42 | 5.72 | 7.09 |
Ipca Laboratories Ltd Quaterly Results
Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | |
INCOME | 1464.31 | 1435.1 | 1529.5 | 1698.81 | 1523.72 |
PROFIT | 115.18 | 84.82 | 166.58 | 162.13 | 136.94 |
EPS | 4.54 | 3.34 | 6.57 | 6.39 | 5.4 |
Profit & Loss (Figures in Rs. Crores)
Ipca Laboratories Ltd Profit & Loss
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | ||
INCOME | 3365.39 | 3245.02 | 2863.48 | 3174.46 | 3276.05 | 3918.79 | 4862.15 | 5677.62 | 6026.01 | 6269.27 | |
PROFIT | 476.67 | 249.95 | 88.69 | 191.73 | 234.38 | 438.99 | 596.85 | 1134.03 | 885.33 | 454.16 | |
EPS | 18.52 | 10.27 | 3.81 | 7.71 | 9.49 | 17.5 | 23.89 | 45.29 | 35.91 | 19.39 |
Ipca Laboratories Ltd Profit & Loss
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | ||
INCOME | 3316.88 | 3188.27 | 2809.07 | 3124.59 | 3211.96 | 3766.39 | 4557.56 | 5372.13 | 5617.22 | 5821.72 | |
PROFIT | 475.49 | 251.84 | 88.89 | 185.45 | 228.18 | 448.61 | 641.6 | 1132.43 | 852.51 | 486.27 | |
EPS | 18.92 | 10.15 | 3.67 | 7.46 | 9.24 | 18 | 25.82 | 44.97 | 33.91 | 19.93 |
Balance Sheet (Figures in Rs. Crores)
Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | |
SOURCES OF FUNDS : | ||||||||||
Share Capital | 25.37 | 25.37 | 25.37 | 25.27 | 25.27 | 25.24 | 25.24 | 25.24 | 25.24 | 25.24 |
Reserves Total | 5,816.65 | 5,439.47 | 4,676.28 | 3,590.27 | 3,097.12 | 2,663.33 | 2,430.02 | 2,233.95 | 2,183.19 | 1,934.42 |
Equity Share Warrants | 0 | 0 | 0 | 11.94 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Shareholders Funds | 5,842.02 | 5,464.84 | 4,701.65 | 3,627.48 | 3,122.39 | 2,688.57 | 2,455.26 | 2,259.19 | 2,208.43 | 1,959.66 |
Minority Interest | 73.3 | 76.92 | 14.53 | 13.63 | 15.54 | 0 | 0 | 0 | 0 | 0 |
Secured Loans | 857.91 | 554.57 | 140.92 | 324.46 | 444.21 | 622.21 | 656.3 | 738.61 | 759.08 | 600.68 |
Unsecured Loans | 623.36 | 252.65 | 124.47 | 176.26 | 20.74 | 5.35 | 59.45 | 128.57 | 175.91 | 1.88 |
Total Debt | 1,481.27 | 807.22 | 265.39 | 500.72 | 464.95 | 627.56 | 715.75 | 867.18 | 934.99 | 602.56 |
Other Liabilities | 47.27 | 44.83 | 40.71 | 34.49 | 26.84 | 27.44 | 26.11 | 21.84 | 22.05 | 18.34 |
Total Liabilities | 7,443.86 | 6,393.81 | 5,022.28 | 4,176.32 | 3,629.72 | 3,343.57 | 3,197.12 | 3,148.21 | 3,165.47 | 2,580.56 |
APPLICATION OF FUNDS : | ||||||||||
Gross Block | 4,364.66 | 3,743.48 | 3,212.19 | 2,985.73 | 2,632.86 | 2,464.33 | 2,318.22 | 2,176.95 | 2,546.33 | 1,932.05 |
Less: Accumulated Depreciation | 1,613.28 | 1,341.29 | 1,139.76 | 927 | 692.48 | 511.37 | 334.95 | 162.77 | 745.9 | 578.46 |
Net Block | 2,751.38 | 2,402.19 | 2,072.43 | 2,058.73 | 1,940.38 | 1,952.96 | 1,983.27 | 2,014.18 | 1,800.43 | 1,353.59 |
Capital Work in Progress | 140.43 | 306.43 | 234.82 | 133.28 | 66.33 | 73 | 94.64 | 128.74 | 267.22 | 164.9 |
Investments | 625.98 | 989.19 | 505.26 | 309.56 | 120.43 | 86.87 | 135.81 | 25.82 | 16.19 | 9.15 |
Inventories | 1,743.37 | 1,857.97 | 1,594.81 | 1,323.12 | 1,072.5 | 880.59 | 882.22 | 837.42 | 926.56 | 847.58 |
Sundry Debtors | 989.02 | 910.78 | 811.75 | 895.2 | 681.51 | 602.27 | 500.16 | 445.87 | 353 | 449.79 |
Cash and Bank Balance | 1,853.24 | 640.66 | 365.07 | 180.92 | 282.3 | 150.57 | 35.85 | 175.54 | 124.79 | 76.01 |
Loans and Advances | 280.32 | 317.99 | 271.5 | 218.22 | 251.06 | 242.7 | 210.02 | 163.09 | 209.63 | 227.89 |
Total Current Assets | 4,865.95 | 3,727.4 | 3,043.13 | 2,617.46 | 2,287.37 | 1,876.13 | 1,628.25 | 1,621.92 | 1,613.98 | 1,601.27 |
Current Liabilities | 862.62 | 945.49 | 797.95 | 840.64 | 684.65 | 535.71 | 526.24 | 520.55 | 436.6 | 427.25 |
Provisions | 130.79 | 119.85 | 114.58 | 101.05 | 88.75 | 78.31 | 65.68 | 66.49 | 35.98 | 55.64 |
Total Current Liabilities & Provisions | 993.41 | 1,065.34 | 912.53 | 941.69 | 773.4 | 614.02 | 591.92 | 587.04 | 472.58 | 482.89 |
Net Current Assets | 3,872.54 | 2,662.06 | 2,130.6 | 1,675.77 | 1,513.97 | 1,262.11 | 1,036.33 | 1,034.88 | 1,141.4 | 1,118.38 |
Deferred Tax Assets | 22.25 | 103.53 | 90.39 | 87.51 | 85.26 | 74.49 | 57.91 | 55.65 | 9.57 | 6.72 |
Deferred Tax Liability | 207.84 | 265.89 | 221.99 | 227.32 | 230.97 | 232.46 | 228.38 | 212.11 | 183.88 | 153.83 |
Net Deferred Tax | -185.59 | -162.36 | -131.6 | -139.81 | -145.71 | -157.97 | -170.47 | -156.46 | -174.31 | -147.11 |
Other Assets | 239.12 | 196.3 | 210.77 | 138.79 | 134.32 | 126.6 | 117.54 | 101.05 | 114.54 | 81.65 |
Total Assets | 7,443.86 | 6,393.81 | 5,022.28 | 4,176.32 | 3,629.72 | 3,343.57 | 3,197.12 | 3,148.21 | 3,165.47 | 2,580.56 |
Contingent Liabilities | 1,960.14 | 69.67 | 55.76 | 42.08 | 40.4 | 43.05 | 45.54 | 47.56 | 255.38 | 366.18 |
Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | |
SOURCES OF FUNDS : | ||||||||||
Share Capital | 25.37 | 25.37 | 25.37 | 25.27 | 25.27 | 25.24 | 25.24 | 25.24 | 25.24 | 25.24 |
Reserves Total | 5,851.93 | 5,450.39 | 4,727.35 | 3,640.33 | 3,111.39 | 2,669.71 | 2,449.88 | 2,257.81 | 2,208.09 | 1,956.37 |
Equity Share Warrants | 0 | 0 | 0 | 11.94 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Shareholders Funds | 5,877.3 | 5,475.76 | 4,752.72 | 3,677.54 | 3,136.66 | 2,694.95 | 2,475.12 | 2,283.05 | 2,233.33 | 1,981.61 |
Secured Loans | 857.91 | 554.57 | 113.53 | 298.19 | 444.21 | 622.21 | 666.3 | 736.62 | 754.71 | 594.7 |
Unsecured Loans | 582.47 | 221.84 | 122.72 | 176.26 | 0 | 5.35 | 49.45 | 128.58 | 174.1 | 0 |
Total Debt | 1,440.38 | 776.41 | 236.25 | 474.45 | 444.21 | 627.56 | 715.75 | 865.2 | 928.81 | 594.7 |
Other Liabilities | 46.85 | 44.33 | 39.44 | 33.24 | 26.84 | 27.44 | 26.11 | 21.78 | 20.87 | 16.98 |
Total Liabilities | 7,364.53 | 6,296.5 | 5,028.41 | 4,185.23 | 3,607.71 | 3,349.95 | 3,216.98 | 3,170.03 | 3,183.01 | 2,593.29 |
APPLICATION OF FUNDS : | ||||||||||
Gross Block | 3,889.09 | 3,364.68 | 2,899.27 | 2,688.79 | 2,412.97 | 2,358.72 | 2,276.99 | 2,137.32 | 2,465.9 | 1,851.29 |
Less : Accumulated Depreciation | 1,410.43 | 1,211.59 | 1,030.67 | 847.82 | 672.87 | 504.11 | 331.02 | 160.74 | 712.94 | 545.18 |
Net Block | 2,478.66 | 2,153.09 | 1,868.6 | 1,840.97 | 1,740.1 | 1,854.61 | 1,945.97 | 1,976.58 | 1,752.96 | 1,306.11 |
Capital Work in Progress | 123.02 | 297.15 | 182 | 84.19 | 65.96 | 73.23 | 94.87 | 128.93 | 266.95 | 164.9 |
Investments | 1,056.73 | 1,338.7 | 867.84 | 648.72 | 322.24 | 215.63 | 211.58 | 97.43 | 81.86 | 28.9 |
Inventories | 1,660.13 | 1,779.54 | 1,517.09 | 1,266.96 | 1,055.55 | 873.17 | 873.54 | 831.93 | 916.98 | 838.3 |
Sundry Debtors | 925.9 | 824.3 | 774.46 | 839.13 | 632.06 | 594.38 | 501.98 | 441.45 | 353.55 | 448.76 |
Cash and Bank Balance | 1,706.06 | 595.5 | 306.92 | 152.4 | 259.81 | 131.03 | 17.53 | 161.98 | 113.19 | 69.22 |
Loans and Advances | 259.74 | 305.81 | 285.49 | 215.37 | 247.75 | 239.24 | 205.03 | 164.41 | 209.34 | 226.21 |
Total Current Assets | 4,551.83 | 3,505.15 | 2,883.96 | 2,473.86 | 2,195.17 | 1,837.82 | 1,598.08 | 1,599.77 | 1,593.06 | 1,582.49 |
Current Liabilities | 773.37 | 866.28 | 733.57 | 758.95 | 616.62 | 522.24 | 516.7 | 513.27 | 431.06 | 422.25 |
Provisions | 129.62 | 117.15 | 113.15 | 99.6 | 86.95 | 76.86 | 65.63 | 65.69 | 35.44 | 54.72 |
Total Current Liabilities & Provisions | 902.99 | 983.43 | 846.72 | 858.55 | 703.57 | 599.1 | 582.33 | 578.96 | 466.5 | 476.97 |
Net Current Assets | 3,648.84 | 2,521.72 | 2,037.24 | 1,615.31 | 1,491.6 | 1,238.72 | 1,015.75 | 1,020.81 | 1,126.56 | 1,105.52 |
Deferred Tax Assets | 18.52 | 101.48 | 88.44 | 85.5 | 83.42 | 75.43 | 57.9 | 55.65 | 9.57 | 6.72 |
Deferred Tax Liability | 197.97 | 259.99 | 223.44 | 226.29 | 229.68 | 234.09 | 226.54 | 211.29 | 183.8 | 153.83 |
Net Deferred Tax | -179.45 | -158.51 | -135 | -140.79 | -146.26 | -158.66 | -168.64 | -155.64 | -174.23 | -147.11 |
Other Assets | 236.73 | 144.35 | 207.73 | 136.83 | 134.07 | 126.42 | 117.45 | 101.92 | 128.91 | 134.97 |
Total Assets | 7,364.53 | 6,296.5 | 5,028.41 | 4,185.23 | 3,607.71 | 3,349.95 | 3,216.98 | 3,170.03 | 3,183.01 | 2,593.29 |
Contingent Liabilities | 1,996.35 | 103.39 | 86.68 | 64.78 | 40.4 | 43.05 | 45.47 | 49.55 | 259.76 | 372.18 |
Cash Flow (Figures in Rs. Crores)
Net Profit before Tax and Extr... | 745.29 |
Depreciation | 261.56 |
Interest (Net) | -33.81 |
P/L on Sales of Assets | -13.21 |
Prov. and W/O (Net) | 0.56 |
P/L in Forex | 18.7 |
Total Adjustments (PBT and Ext... | 235.18 |
Operating Profit before Workin... | 980.47 |
Trade and 0ther Receivables | -68.1 |
Inventories | 114.6 |
Trade Payables | -32.4 |
Total Adjustments (OP before W... | 48.99 |
Cash Generated from/(used in) ... | 1,029.46 |
Direct Taxes Paid | -223.65 |
Total Adjustments(Cash Generat... | -223.65 |
Cash Flow before Extraordinary... | 805.81 |
Net Cash from Operating Activi... | 805.81 |
Purchased of Fixed Assets | -494.47 |
Sale of Fixed Assets | 36.15 |
Interest Received | 54.23 |
Invest.In Subsidiaires | -10.59 |
Investment in Group Cos. | -45.34 |
Net Cash used in Investing Act... | -725 |
Proceed from 0ther Long Term B... | 391.69 |
Proceed from Short Tem Borrowi... | 294.27 |
Of the Long Tem Borrowings | -28.25 |
Of Financial Liabilities | -7.51 |
Dividend Paid | -101.48 |
Interest Paid | -41.48 |
Net Cash used in Financing Act... | 507.24 |
Net Profit before Tax and Extr... | 750.49 |
Depreciation | 228.63 |
Interest (Net) | -29.84 |
P/L on Sales of Assets | -13.21 |
Prov. and W/O (Net) | 0.56 |
P/L in Forex | 18.57 |
Total Adjustments (PBT and Ext... | 206.09 |
Operating Profit before Workin... | 956.58 |
Trade and 0ther Receivables | -101.31 |
Inventories | 119.41 |
Trade Payables | -40.88 |
Total Adjustments (OP before W... | 20.96 |
Cash Generated from/(used in) ... | 977.54 |
Direct Taxes Paid | -215.25 |
Total Adjustments(Cash Generat... | -215.25 |
Cash Flow before Extraordinary... | 762.29 |
Net Cash from Operating Activi... | 762.29 |
Purchased of Fixed Assets | -436.87 |
Sale of Fixed Assets | 36.15 |
Interest Received | 49.37 |
Invest.In Subsidiaires | -68.46 |
Investment in Group Cos. | -45.34 |
Net Cash used in Investing Act... | -709.61 |
Proceed from 0ther Long Term B... | 391.69 |
Proceed from Short Tem Borrowi... | 289.58 |
Of the Long Tem Borrowings | -28.25 |
Of Financial Liabilities | -5.28 |
Dividend Paid | -101.48 |
Interest Paid | -39.88 |
Net Cash used in Financing Act... | 506.38 |
Company Details
Registered Office |
|
Address | 48 Kandivli Industrial Estate, Kandivli (West) |
City | Mumbai |
State | Maharashtra |
Pin Code | 400067 |
Tel. No. | 91-22-66474444 |
Fax. No. | 91-22-28686613 |
investors@ipca.com ; ipca@ipca.com | |
Internet | http://www.ipca.com |
Registrars |
|
Address | 48 Kandivli Industrial Estate |
City | Mumbai |
State | Maharashtra |
Pin Code | 400067 |
Tel. No. | 91-22-66474444 |
Fax. No. | 91-22-28686613 |
investors@ipca.com ; ipca@ipca.com | |
Internet | http://www.ipca.com |
Management |
|
Name | Designation |
Premchand Godha | Chairman / Executive Director |
A K Jain | Joint Managing Director & CFO |
Pranay Godha | ED / MD / CEO / Promoter |
Prashant Godha | Executive Director |
Anand T Kusre | Independent Non Exe. Director |
Manisha Premnath | Independent Non Exe. Director |
Kamal Kishore Seth | Independent Non Exe. Director |
Narendra Mairpady | Independent Non Exe. Director |
Harish P Kamath | Company Sec. & Compli. Officer |